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Clinics and pathology 
Disease 
Myoepithelioma tumours of soft tissue cover a wide 
range of tumours of various behaviour. While most are 
of intermediate aggressivity, some metastasize. There is 
no sex ratio predominance. Mean age at diagnosis is 38
years; with a range of 3-83 years. Of a hundred of cases 
reviewed by Hornick and Fletcher (2003), 60% were 
benign and classified as myoepitheliomas or mixed 
tumors, and 40% were classified as myoepithelial 
carcinomas or malignant mixed tumours.  
Amongst cases with benign or low-grade cytology, 
with a mean follow-up of 3 years, 20% recurred localy 
and none metastasized. Amongst cytologically 
malignant cases, with a mean follow-up of 4 years, 
40% recurred locally, 1/3 metastasized, and 4 out of 31 
patients died. Tumours are positive for epithelial 
markers, and for S100 or GFAP, or myogenic markers 
(Gleason and Fletcher, 2007). 
Epidemiology 
One case to date, a 40-year-old female patient. After 
surgical removal, recurrences occured during 2 years, 
and metastases appeared 3 years later. The patient 





















From N-term to C-term: a transactivation domain 
(TAD) containing multiple degenerate hexapeptide 
repeats, 3 arginine/glycine rich domains (RGG 
regions), a RNA recognition motif, and a RanBP2 type 
Zinc finger. Role in transcriptional regulation for 
specific genes and in mRNA splicing. 




5' EWSR1 - 3' ZNF444; fuses EWSR1 exon 8 to the 
very near end of ZNF444 (at nucleotide 967, while th  
full transcript of ZNF444 is 984 nt long!). 
Fusion Protein 
Description 
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ZNF444. This does not fit with the usual model of 
carcinogenesis found with other EWSR1 translocations, 
were there is fusion of the N terminal transactivation 
domain of EWSR1 to the DNA binding domain of the 
partner (e.g. FLI1). 
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